Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene results in increased expression of FMN1 mRNA | increases expression | 20406850
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in decreased expression of FMN1 mRNA | decreases expression | 20064835
|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of FMN1 mRNA | decreases expression | 20382639
|
D004997 |
Ethinyl Estradiol |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of FMN1 mRNA | affects cotreatment|decreases expression | 17942748
|
D008070 |
Lipopolysaccharides |
Lipopolysaccharides results in increased expression of FMN1 mRNA | increases expression | 12057914
|
D010634 |
Phenobarbital |
NR1I3 protein affects the reaction [Phenobarbital results in decreased expression of FMN1 mRNA] | affects reaction|decreases expression | 19482888
|
D010634 |
Phenobarbital |
Phenobarbital results in decreased expression of FMN1 mRNA | decreases expression | 19482888
|
D013749 |
Tetrachlorodibenzodioxin |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of FMN1 mRNA | affects cotreatment|decreases expression | 17942748
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Phenobarbital |
9.65 | 6195326 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
9.65 | 15322242 11752688 14514962 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
4.38 | 17505938 |
MESH:D055371 |
Acute Lung Injury |
|
Lipopolysaccharides |
4.33 | 18653653 11850527 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
4.37 | 20464547 20127859 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
4.37 | 14692618 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
2.80 | 6695378 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Phenobarbital |
11.44 | 17620307 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
11.44 | 16835633 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
3.21 | 11748828 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
4.43 | 19183758 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
3.82 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
2.82 | 15885639 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
3.33 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
4.23 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.93 | 15746008 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
1.87 | 20146248 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
1.87 | 20435547 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
3.02 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
3.12 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Phenobarbital |
3.12 | 17173139 1701930 20935162 20007298 6705139 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
2.11 | 20419170 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.50 | 16120746 18670907 18850075 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
7.26 | 6135515 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7.26 | 20889678 |
MESH:D002493 |
Central Nervous System Diseases |
|
Phenobarbital |
4.61 | 4080065 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.41 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
3.07 | 17333356 16919318 15861022 17681005 17110522 11677210 16105132 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.20 | 15668235 15340226 12621046 8697196 16354765 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.31 | 14669216 17141729 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
1.26 | 10048152 15322242 20055451 |
MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
4.38 | 18551238 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.72 | 17107852 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
3.92 | 18551238 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
3.92 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.96 | 11462148 |
MESH:D004421 |
Dystonia |
|
Phenobarbital |
4.31 | 1851702 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
2.65 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
4.35 | 16714409 15322242 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
3.52 | 12538720 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.29 | 9294722 10568697 |
MESH:D019446 |
Endotoxemia |
|
Lipopolysaccharides |
4.79 | 15821434 17637181 15328337 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Phenobarbital |
4.47 | 3659116 |
MESH:D004828 |
Epilepsies, Partial |
|
Phenobarbital |
4.31 | 3922381 11558140 |
MESH:D004827 |
Epilepsy |
|
Phenobarbital |
3.01 | 20417680 |
MESH:D004832 |
Epilepsy, Absence |
|
Phenobarbital |
3.79 | 6401628 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Phenobarbital |
4.61 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Phenobarbital |
4.41 | 3659116 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
4.54 | 20426865 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
4.54 | 16530937 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.21 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
3.09 | 15345470 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.81 | 11858732 |
MESH:D005334 |
Fever |
|
Lipopolysaccharides |
4.28 | 9205823 11852909 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
3.31 | 20067830 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
5.04 | 10696789 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
6.88 | 20471113 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
6.88 | 10048152 11294989 |
MESH:D006463 |
Hemolytic-Uremic Syndrome |
|
Lipopolysaccharides |
4.65 | 16366002 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.62 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
Phenobarbital |
9.66 | 16109766 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
9.66 | 16120746 15340226 12621046 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.49 | 15340226 16959395 18606429 16354765 8697196 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
1.99 | 18850075 18670907 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
4.17 | 16569931 16945680 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.77 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
2.66 | 17937319 |
MESH:D007249 |
Inflammation |
|
Lipopolysaccharides |
5.51 | 12878042 9205823 17237260 17963957 17255318 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
5.51 | 12200463 12878042 |
MESH:D019189 |
Iron Metabolism Disorders |
|
Lipopolysaccharides |
4.93 | 17255318 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.62 | 16580747 |
MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
3.21 | 16705839 |
MESH:D007970 |
Leukopenia |
|
Lipopolysaccharides |
5.09 | 15821434 |
MESH:D008103 |
Liver Cirrhosis |
|
Phenobarbital |
3.03 | 21047994 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Lipopolysaccharides |
2.54 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
2.54 | 12878042 |
MESH:D008107 |
Liver Diseases |
|
Phenobarbital |
2.22 | 19363144 |
MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
11.43 | 7678174 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
11.43 | 20195826 21137059 |
MESH:D008113 |
Liver Neoplasms |
|
Phenobarbital |
11.43 | 19812893 8742319 19073162 19482888 15975961 21047994 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
11.43 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
10.75 | 2876784 2876786 6135515 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Phenobarbital |
10.75 | 18308698 17172636 1399818 6150874 2563599 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
10.75 | 12151625 |
MESH:D055370 |
Lung Injury |
|
Lipopolysaccharides |
4.36 | 21114838 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
2.25 | 18816296 20464547 18569708 20869020 17053015 20064080 18520028 20135361 6695378 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
2.25 | 19555203 11884234 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
3.40 | 16381670 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.24 | 12213967 |
MESH:D020191 |
Myoclonic Epilepsies, Progressive |
|
Phenobarbital |
4.87 | 17484760 |
MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
4.26 | 18551238 7678174 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
2.28 | 11141357 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
3.54 | 14600291 |
MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
3.70 | 16049721 |
MESH:D010018 |
Osteomalacia |
|
Phenobarbital |
4.76 | 17016548 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Phenobarbital |
2.57 | 16965848 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.99 | 11578682 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.69 | 12520081 |
MESH:D011014 |
Pneumonia |
|
Lipopolysaccharides |
4.95 | 12224865 11605937 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.89 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Phenobarbital |
3.87 | 2563599 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
3.59 | 11118676 11896295 11399792 11222880 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
2.93 | 17292933 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
3.71 | 16919318 15861022 |
MESH:D019310 |
Pseudolymphoma |
|
Phenobarbital |
4.94 | 12752131 |
MESH:D012130 |
Respiratory Hypersensitivity |
|
Lipopolysaccharides |
3.90 | 10835634 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
4.17 | 18990726 |
MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
6.53 | 18551238 |
MESH:D012640 |
Seizures |
|
Phenobarbital |
6.53 | 3137016 11442880 16876388 4039156 |
MESH:D003294 |
Seizures, Febrile |
|
Phenobarbital |
5.22 | 6407741 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
5.85 | 10029692 19755658 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
5.85 | 16192470 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
4.38 | 16709447 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
1.56 | 2093021 20155912 |
MESH:D013921 |
Thrombocytopenia |
|
Lipopolysaccharides |
4.43 | 15821434 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.92 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
3.40 | 15669648 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
4.35 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
Phenobarbital |
3.26 | 1399818 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
5.28 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
5.28 | 17053015 |
MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
4.71 | 10091137 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
3.63 | 14692618 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
5.04 | 12125929 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.82 | 15869587 14671159 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.69 | 15886252 |